<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05072626</url>
  </required_header>
  <id_info>
    <org_study_id>（2020）287</org_study_id>
    <nct_id>NCT05072626</nct_id>
  </id_info>
  <brief_title>High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia</brief_title>
  <official_title>Study on High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia After Kasai Portoenterostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, single-center, randomized controlled, parallel, and open&#xD;
      clinical study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Medium-chain triglyceride（MCT） remains a key component of supplementation in cholestasis. The&#xD;
      limited data point to improved growth in cholestatic infants fed with a ratio of MCT/&#xD;
      long-chain triglyceride (LCT) supplementation of 30% to 70% (MCT/LCT mix). It is important to&#xD;
      highlight that MCTs are less efficient fuel sources, as MCTs contain fewer kilocalories per&#xD;
      gram than LCTs (8.3 kcal/g MCT vs 9 kcal/g LCT), increase total energy expenditure, and are&#xD;
      not a source of essential fatty acids. For this reason, a diet of exclusive MCT lipids (&gt;80%,&#xD;
      or lower in severe cholestasis) increases the risk of Essential Fatty Acid Deficiency and may&#xD;
      contribute to suboptimal weight gain. Supplementation of the diet with MCT may be offered in&#xD;
      the form of both MCT supplementation and MCT-containing formulas. it should be noted that&#xD;
      while the practice of enriching the diet with MCT oils in the clinical setting is&#xD;
      commonplace, a trial comparing MCT to LCT supplementation has never been performed in&#xD;
      pediatric cholestasis. A total of 300 infants with Congenital Biliary Atresia after Kasai&#xD;
      Portoenterostomy will be enrolled ( randomly divided 150 in the experimental group and 150 in&#xD;
      the control group). To evaluate the efficacy, safety, and tolerance of MCT supplementation&#xD;
      with breast milk and formula compared with high MCT formula.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 15, 2021</start_date>
  <completion_date type="Anticipated">September 25, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A total of 300 infants &lt; 3 months old with Congenital Biliary Atresia after Kasai Portoenterostomy will be enrolled. Randomized grouping, the patients will be fed with high MCT formula milk with breast milk (or infant formula) or MCT supplementation with breast milk (or infant formula) after the Kasai procedure.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Z-scores of body weight</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>The patient will be weighed in the recumbent position on an electronic infant scale. Z-scores for weight for age (WAZ) were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Z-scores of body length</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of body length</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of body length</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of body length</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of body weight</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of body weight</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of body weight</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of head circumference</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of head circumference</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of head circumference</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Z-scores of head circumference</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin A</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin A</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin A</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin A</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of 25（OH) D</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of 25（OH) D</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of 25（OH） D</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of 25（OH） D</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin E</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin E</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin E</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin E</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin K</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin K</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin K</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>level of vitamin K</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aspartate aminotransferase</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aspartate aminotransferase</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aspartate aminotransferase</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aspartate aminotransferase</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alanine aminotransferase</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alanine aminotransferase</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alanine aminotransferase</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alanine aminotransferase</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Bilirubin</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Bilirubin</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Bilirubin</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Bilirubin</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct Bilirubin</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct Bilirubin</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct Bilirubin</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct Bilirubin</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gamma-glutamyl transferase</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gamma-glutamyl transferase</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gamma-glutamyl transferase</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gamma-glutamyl transferase</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total bile acid</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total bile acid</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total bile acid</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total bile acid</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>White blood cell</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>White blood cell</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>White blood cell</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>White blood cell</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lymphocyte</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lymphocyte</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lymphocyte</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lymphocyte</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil count</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil count</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil count</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil count</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Normalized Ratio</measure>
    <time_frame>1 month after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Normalized Ratio</measure>
    <time_frame>3 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Normalized Ratio</measure>
    <time_frame>6 months after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>International Normalized Ratio</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Blood biochemical data are from clinical database.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative cholangitis</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Data from clinical database</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver transplantation</measure>
    <time_frame>1 year after Kasai portoenterostomy</time_frame>
    <description>Data from clinical database</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Biliary Atresia</condition>
  <condition>Infant</condition>
  <condition>Nutrition Support</condition>
  <condition>Medium-chain Triglyceride</condition>
  <arm_group>
    <arm_group_label>high MCT formula with breast milk (or infant formula)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>high MCT formula with breast milk（or infant formula）: Patients will be enrolled from 4 to 5 days after the Kasai operation. Daily dose: according to the amount of enteral nutrition, q2h, q3h, or tube feeding.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MCT powder with breast milk (or infant formula)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be enrolled from 4 to 5 days after the Kasai operation. Daily dose: according to the amount of enteral nutrition, q2h, q3h, or tube feeding.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>high MCT formula</intervention_name>
    <description>Alfaré(Nestlé Health Science China, including 39% of MCT) with breast milk (or infant formula). Alfaré can be fed with moderate concentration(3.45 tablespoons of 90ml water - 4 tablespoons of 90ml water), and the total energy can be increased by 7.3-16.8kcal/kg/day.</description>
    <arm_group_label>high MCT formula with breast milk (or infant formula)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>MCT powder</intervention_name>
    <description>MCT supplement 1-2g/kg/day combined with breast milk (or infant formula), the total energy can be increased by 7.3-14.6kcal/kg/day.</description>
    <arm_group_label>MCT powder with breast milk (or infant formula)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type III biliary atresia hepatojejunostomy；&#xD;
&#xD;
          -  Gestational age at birth ≥ 36 weeks；&#xD;
&#xD;
          -  Infants aged 0-3months；&#xD;
&#xD;
          -  Weight ≥ 2kg when entering the group；&#xD;
&#xD;
          -  Informed consent of family members&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There are known immune deficiencies；&#xD;
&#xD;
          -  Severe surgical complications (such as intestinal obstruction, massive bleeding, etc.)&#xD;
             -occurred during or within 72 hours after the operation；&#xD;
&#xD;
          -  The child's mother has human immunodeficiency disease, or HBsAg positive, or HCV&#xD;
             positive；&#xD;
&#xD;
          -  Complicated with other systemic serious diseases (such as congenital multiple&#xD;
             malformations, chromosome abnormalities, and CMV infection)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tian Qian, M.D. PhD</last_name>
    <role>Study Director</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tian Qian, M.D. PhD</last_name>
    <phone>+8602164931981</phone>
    <email>drqiantian@fudan.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaoyan Gong, Bachelor</last_name>
    <phone>+8602164931980</phone>
    <email>xygongfudan@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Tian Qian, M.D.</last_name>
      <phone>02164931981</phone>
      <email>drqiantian@fudan.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xianyan Gong, Bachelor</last_name>
      <phone>02164931980</phone>
      <email>xygongfudan@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 13, 2021</study_first_submitted>
  <study_first_submitted_qc>October 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Fudan University</investigator_affiliation>
    <investigator_full_name>Qian Tian</investigator_full_name>
    <investigator_title>Deputy Director of clinical Nutrition</investigator_title>
  </responsible_party>
  <keyword>Biliary Atresia</keyword>
  <keyword>Kasai portoenterostomy</keyword>
  <keyword>Nutrition Support</keyword>
  <keyword>medium-chain triglyceride</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Biliary Atresia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

